Navigation Links
Gen-Probe Reports Financial Results for the Second Quarter of 2011
Date:7/28/2011

er 31,20112010(Unaudited)AssetsCurrent assets:Cash and cash equivalents

$  176,719$  59,690Marketable securities

212,499170,648Trade accounts receivable, net of allowance for doubtful accounts of $414 and $355 at June 30, 2011 and December 31, 2010, respectively

52,74254,739Accounts receivable — other

3,5695,493Inventories

70,66666,416Deferred income tax

13,16913,634Prepaid income tax

2932,993Prepaid expenses

15,93611,672Other current assets

5,1245,148Total current assets

550,717390,433Marketable securities, net of current portion

140,227259,317Property, plant and equipment, net

169,262160,863Capitalized software, net

15,02013,981Patents, net

12,11512,450Goodwill

150,830150,308Purchased intangibles, net

116,006120,270License, manufacturing access fees and other assets, net

65,56360,175Total assets

$  1,219,740$1,167,797Liabilities and stockholders' equityCurrent liabilities:Accounts payable

$  11,358$  14,614Accrued salaries and employee benefits

22,94726,825Other accrued expenses

13,93913,935Income tax payable

5,470634Short-term borrowings

248,000240,000Deferred income tax

97-Deferred revenue

1,3871,166Total current liabilities

303,198297,174Non-current income tax payable

9,0418,315Deferred income tax

27,95529,775Deferred revenue, net of current portion

2,2692,500Other long-term liabilities

7,4606,654Commitments and contingenciesStockholders' equity:Preferred stock, $0.0001 par value per share; 20,000,000 shares authorized, none issued and outstanding

——Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 48,170,514 and 47,966,156 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively

55Additional paid-in capit
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
2. Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
3. Gen-Probe to Webcast Presentation at the Bank of America 38th Annual Investment Conference
4. Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference
5. Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
6. Promising Clinical Data on Gen-Probes APTIMA(R) HPV Test Presented at Major European Medical Meeting
7. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call
8. Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
9. Gen-Probe Borrows $170 Million Under New Line of Credit
10. Gen-Probe to Webcast Two Upcoming Investor Presentations
11. Gen-Probe Completes Acquisition of Tepnel Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... James Sherley says he has been working towards ... since his days as a principal investigator at the Fox ... Sherley founded the ASCTC as a new Boston biotech ... property developed in Sherley’s research over the years since FCCC, ... (MIT), and more recently as a senior scientist at the ...
(Date:10/30/2014)... 30, 2014 Isis Pharmaceuticals, Inc. (NASDAQ: ... management will present a company overview at the Nomura Biotechnology ... in Boston, MA. A ... "Investors & Media" section of the Company,s website, www.isispharm.com ... within 48 hours and will be archived for a limited ...
(Date:10/27/2014)... 27, 2014 Ryan Carfley , Managing ... to sit down with Bryan Hamilton, the publisher of the ... discuss talent in the Research Triangle region of North Carolina. ... highlighted at the roundtable include the role of social ... of work/life balance and the unique role that Millennials play ...
(Date:10/27/2014)... The “Molecular Diagnostic Market by ... INAAT, DNA Sequencing), End User (Hospital, Laboratories), & ... Forecast to 2018” provides a detailed overview of ... trends, and strategies impacting the global molecular diagnostics ... the revenue and share analysis. , The global ...
Breaking Biology Technology:Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 2Personify's Ryan Carfley Talks Recruiting with Triangle Business Journal, RPG Solutions 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 4Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 5
... Bill Gates , Co-Chair and Trustee of the Bill & Melinda ... mobile technologies to improve health outcomes in the developing world at ... The summit, organized by the Foundation for the National Institutes of ... the mHealth Alliance, will be held November 8-10 in ...
... ROCKVILLE, Md. , Aug. 2 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: ... and commercialization of products for central nervous system disorders, today announced it will ... 2010 , before the market opens. A full text copy of the release ... , , ...
... 2 Tengion Inc. (Nasdaq: TNGN ) ... the position of Chief Financial Officer.  Mr. Davis comes to Tengion after ... to develop improved protein therapeutics. At its peak, Neose employed 200 individuals, ... , , ...
Cached Biology Technology:Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 2Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 3Bill Gates Named Keynote Speaker at the 2010 mHealth Summit 4Vanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010 2Tengion Appoints A. Brian Davis Chief Financial Officer 2
(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... their food, but they also need protection from its harmful ... of molecules in plants that shields them from sun damage. ... American Chemical Society , one team reports on the mechanics ... and colleagues at Purdue University note that the harsh ultraviolet ... to plant DNA and, as a result, hinder plant growth. ...
(Date:10/29/2014)... German . ... Peter Schlögelhofer at the Max F. Perutz Laboratories (MFPL) ... of Vienna dived into the process of meiosis in ... an inversion of the standard meiotic phases. The researchers ... Nature Communications . , Meiosis is the two-step series ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2Meiotic cell division 'the other way round' 2
... Aluminum salts, or alum, have been injected into billions of ... one knows, however, how they boost the immune response. In ... the National Academy of Sciences researchers at National Jewish ... that host DNA coats the alum adjuvant and induces two ...
... N.C. -- The cost of complying with tougher EPA air-quality ... toward natural gas for electricity generation, according to a new ... particulate matter, nitrogen oxide and mercury may make nearly two-thirds ... as plants powered by natural gas, the study finds. ...
... Engineering Professor Tim Bender and Post-Doctoral Fellow Benoit ... polymer synthesis could have implications for the manufacture ... and even medical implants, the researchers say. ... subphthalocyanine polymers by facile coupling to poly (acrylic ...
Cached Biology News:Vaccine adjuvant uses host DNA to boost pathogen recognition 2Vaccine adjuvant uses host DNA to boost pathogen recognition 3New emissions standards would fuel shift from coal to natural gas 2Accidental discovery may lead to improved polymers 2
... agarose is used for second-dimension SDS-PAGE ... in place in PROTEAN Plus cells. ... to allow monitoring of electrophoresis runs. ... agarose in 1x Tris, glycine, SDS, ...
... HV high-voltage power supply, with temperature probe, 100-120 ... 5,000 V, 500 mA, and 400 W. The ... between 0 and 90 degrees C during electrophoresis. ... Power cord and instructions are provided. Dimensions are ...
The stirbar is used in the buffer tank of the Trans-Blot Plus cell to maintain uniform conductivity and temperature during electrophoretic transfer. Dimensions are 3.5 x 0.5 in....
... cooling coil, Trans-Blot cell, provides ... high-intensity, and extended electrophoretic transfer ... Trans-Blot cell. Use of the ... to an external water recirculator, ...
Biology Products: